PFSA Profusa, Inc.
$2.43▼ -2.80%
Healthcare
Other
After hours
$2.49▲ +2.47%
Sep 11, 7:31 PM ET
Volume 77.3K
Avg Volume (10D) 350.6K
Key Metrics & Fundamentals
Market Cap
$1.47M
P/E Ratio
–
Div Yield
–%
52W Range
2.35 - 3420.00
% vs 50 MA
-59.46%
% vs 200 MA
-99.07%
RSI-14
42.6
MACD Histogram
-0.0600
Beta (1Y vs SPY)
0.10
Free Cash Flow
-$2.71M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$9.15M
COGS
–
Operating Exp
$2.55M
Operating Income
-$2.55M
EBIT
-$2.55M
Pretax Income
-$8.76M
Net Income
-$8.76M
EPS (Diluted)
-151.80
Price & Volume History
Loading chart…
Recent News

Profusa, Inc. Announces Compliance with Nasdaq Publicly Held Shares Requirement
GlobeNewswire · Aug 31, 2026 12:50 PM
Top Midday Decliners
MT Newswires · Aug 20, 2026 6:14 PM

Profusa Advances G3 Vision Labs Acquisition Conditions as Q2 Net Loss Widens
InvestorsHub · Aug 20, 2026 2:49 PM

Profusa Announces Q2 2026 Financial Results and Progress on the Option Agreement Conditions to Close with G3 Vision Labs, a Commercial Stage Diagnostics Company
GlobeNewswire · Aug 20, 2026 12:30 PM
Top Premarket Decliners
MT Newswires · Aug 19, 2026 11:35 AM
BC-Most Active Stocks
Associated Press · Aug 18, 2026 2:30 PM
Top Premarket Gainers
MT Newswires · Aug 18, 2026 11:14 AM

Profusa Announces 1-for-4 Reverse Stock Split
GlobeNewswire · Aug 13, 2026 11:00 AM
Profusa vies for potential G3 Vision Labs acquisition
Medical Device Network · Aug 3, 2026 11:17 AM
Profusa Announces Signing of Option Agreement for the Acquisition of a Commercial Stage Diagnostics Company, G3 Vision Labs
GlobeNewswire · Jul 31, 2026 9:15 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See PFSA's money flow as a full page
Social Sentiment
Avg +0.90 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.